Management and Surveillance of Short- and Long-Term Sequelae of Radiation Therapy for the Treatment of Pediatric Brain Tumors

Fred Chiu-Lai Lam; Ekkehard M Kasper; Anand Mahadevan

doi:10.1055/s-0040-1715501

Journal of Pediatric Neurology, Table of Contents

Journal of Pediatric Neurology 2020; 18(06): 307-312
DOI: 10.1055/s-0040-1715501

Review Article

Management and Surveillance of Short- and Long-Term Sequelae of Radiation Therapy for the Treatment of Pediatric Brain Tumors

Fred Chiu-Lai Lam

¹Division of Neurosurgery, McMaster University, Hamilton, Ontario, Canada

,

Ekkehard M Kasper

¹Division of Neurosurgery, McMaster University, Hamilton, Ontario, Canada

,

Anand Mahadevan

²Division of Radiation Oncology, Geisinger Health, Danville, Pennsylvania, United States

› Author Affiliations

Abstract

Radiation therapy (RT) is a mainstay for the treatment of pediatric brain tumors. As improvements in and sophistication of this modality continue to increase the survival of patients, the long-term sequelae of RT pose significant challenges in the clinical management of this patient population as they transition into adulthood. In this special edition, we review the short- and long-term effects of RT for the treatment of pediatric brain tumors and the necessary surveillance required for follow-up.

Keywords

pediatric brain tumors - radiation therapy - sequelae - surveillance

Full Text

References

References
1 Smith MA, Freidlin B, Ries LA, Simon R. Trends in reported incidence of primary malignant brain tumors in children in the United States. J Natl Cancer Inst 1998; 90 (17) 1269-1277
2 Packer RJ. Brain tumors in children. Arch Neurol 1999; 56 (04) 421-425
3 Armstrong GT, Liu Q, Yasui Y. et al. Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study. J Natl Cancer Inst 2009; 101 (13) 946-958
4 Soussain C, Ricard D, Fike JR, Mazeron JJ, Psimaras D, Delattre JY. CNS complications of radiotherapy and chemotherapy. Lancet 2009; 374 (9701): 1639-1651
5 Mandell LR, Walker RW, Steinherz P, Fuks Z. Reduced incidence of the somnolence syndrome in leukemic children with steroid coverage during prophylactic cranial radiation therapy. Results of a pilot study. Cancer 1989; 63 (10) 1975-1978
6 Lee AW, Foo W, Chappell R. et al. Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1998; 40 (01) 35-42
7 Perry A, Schmidt RE. Cancer therapy-associated CNS neuropathology: an update and review of the literature. Acta Neuropathol 2006; 111 (03) 197-212
8 Indelicato DJ, Flampouri S, Rotondo RL. et al. Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy. Acta Oncol 2014; 53 (10) 1298-1304
9 Ruben JD, Dally M, Bailey M, Smith R, McLean CA, Fedele P. Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy. Int J Radiat Oncol Biol Phys 2006; 65 (02) 499-508
10 Lee RP, Lucas Jr JT, Tinkle CL, Merchant TE, Boop FA. Pediatric radiotherapy: surgical considerations, sequelae, and future directions. In: Di Rocco C, Pang D, Rutka J. eds. Textbook of Pediatric Neurosurgery. Cham: Springer; 2017
11 Mehta S, Shah A, Jung H. Diagnosis and treatment options for sequelae following radiation treatment of brain tumors. Clin Neurol Neurosurg 2017; 163: 1-8
12 Kumar AJ, Leeds NE, Fuller GN. et al. Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology 2000; 217 (02) 377-384
13 Dequesada IM, Quisling RG, Yachnis A, Friedman WA. Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study. Neurosurgery 2008; 63 (05) 898-903 , discussion 904
14 Stockham AL, Tievsky AL, Koyfman SA. et al. Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery. J Neurooncol 2012; 109 (01) 149-158
15 Hustinx R, Pourdehnad M, Kaschten B, Alavi A. PET imaging for differentiating recurrent brain tumor from radiation necrosis. Radiol Clin North Am 2005; 43 (01) 35-47
16 Le Jeune FP, Dubois F, Blond S, Steinling M. Sestamibi technetium-99m brain single-photon emission computed tomography to identify recurrent glioma in adults: 201 studies. J Neurooncol 2006; 77 (02) 177-183
17 Kohshi K, Imada H, Nomoto S, Yamaguchi R, Abe H, Yamamoto H. Successful treatment of radiation-induced brain necrosis by hyperbaric oxygen therapy. J Neurol Sci 2003; 209 (1-2): 115-117
18 Chuba PJ, Aronin P, Bhambhani K. et al. Hyperbaric oxygen therapy for radiation-induced brain injury in children. Cancer 1997; 80 (10) 2005-2012
19 Mathieu D, Marroni A, Kot J. Tenth European Consensus Conference on Hyperbaric Medicine: recommendations for accepted and non-accepted clinical indications and practice of hyperbaric oxygen treatment. Diving Hyperb Med 2017; 47 (01) 24-32
20 Chan AS, Cheung MC, Law SC, Chan JH. Phase II study of alpha-tocopherol in improving the cognitive function of patients with temporal lobe radionecrosis. Cancer 2004; 100 (02) 398-404
21 Ali FS, Arevalo O, Zorofchian S. et al. Cerebral radiation necrosis: incidence, pathogenesis, diagnostic challenges, and future opportunities. Curr Oncol Rep 2019; 21 (08) 66
22 Fabiano AJ, Qiu J. Post-stereotactic radiosurgery brain metastases: a review. J Neurosurg Sci 2015; 59 (02) 157-167
23 Glantz MJ, Burger PC, Friedman AH, Radtke RA, Massey EW, Schold Jr SC. Treatment of radiation-induced nervous system injury with heparin and warfarin. Neurology 1994; 44 (11) 2020-2027
24 Torcuator R, Zuniga R, Mohan YS. et al. Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis. J Neurooncol 2009; 94 (01) 63-68
25 Klein M, Heimans JJ, Aaronson NK. et al. Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 2002; 360 (9343): 1361-1368
26 Wang Y, Pan L, Sheng X. et al. Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients. Eur J Med Res 2012; 17: 25
27 Rahmathulla G, Marko NF, Weil RJ. Cerebral radiation necrosis: a review of the pathobiology, diagnosis and management considerations. J Clin Neurosci 2013; 20 (04) 485-502
28 McPherson CM, Warnick RE. Results of contemporary surgical management of radiation necrosis using frameless stereotaxis and intraoperative magnetic resonance imaging. J Neurooncol 2004; 68 (01) 41-47
29 Khan RB, Hunt DL, Boop FA. et al. Seizures in children with primary brain tumors: incidence and long-term outcome. Epilepsy Res 2005; 64 (03) 85-91
30 Monje M, Fisher PG. Neurological complications following treatment of children with brain tumors. J Pediatr Rehabil Med 2011; 4 (01) 31-36
31 Packer RJ, Gurney JG, Punyko JA. et al. Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study. J Clin Oncol 2003; 21 (17) 3255-3261
32 Strenger V, Sovinz P, Lackner H. et al. Intracerebral cavernous hemangioma after cranial irradiation in childhood. Incidence and risk factors. Strahlenther Onkol 2008; 184 (05) 276-280
33 Lew SM, Morgan JN, Psaty E, Lefton DR, Allen JC, Abbott R. Cumulative incidence of radiation-induced cavernomas in long-term survivors of medulloblastoma. J Neurosurg 2006; 104 (02) 103-107
34 Baumgartner JE, Ater JL, Ha CS. et al. Pathologically proven cavernous angiomas of the brain following radiation therapy for pediatric brain tumors. Pediatr Neurosurg 2003; 39 (04) 201-207
35 Heckl S, Aschoff A, Kunze S. Radiation-induced cavernous hemangiomas of the brain: a late effect predominantly in children. Cancer 2002; 94 (12) 3285-3291
36 Jensen FK, Wagner A. Intracranial aneurysm following radiation therapy for medulloblastoma. A case report and review of the literature. Acta Radiol 1997; 38 (01) 37-42
37 Bowers DC, Liu Y, Leisenring W. et al. Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2006; 24 (33) 5277-5282
38 Bowers DC, Mulne AF, Reisch JS. et al. Nonperioperative strokes in children with central nervous system tumors. Cancer 2002; 94 (04) 1094-1101
39 Price RA, Birdwell DA. The central nervous system in childhood leukemia. III. Mineralizing microangiopathy and dystrophic calcification. Cancer 1978; 42 (02) 717-728
40 Harrod-Kim P, Kadkhodayan Y, Derdeyn CP, Cross III DT, Moran CJ. Outcomes of carotid angioplasty and stenting for radiation-associated stenosis. AJNR Am J Neuroradiol 2005; 26 (07) 1781-1788
41 Yu SC, Zou WX, Soo YO. et al. Evaluation of carotid angioplasty and stenting for radiation-induced carotid stenosis. Stroke 2014; 45 (05) 1402-1407
42 Passos J, Nzwalo H, Marques J. et al. Late cerebrovascular complications after radiotherapy for childhood primary central nervous system tumors. Pediatr Neurol 2015; 53 (03) 211-215
43 Gebauer J, Baust K, Bardi E. et al. Guidelines for long-term follow-up after childhood cancer: practical implications for the daily work. Oncol Res Treat 2020; 43 (03) 61-69
44 Amirjamshidi A, Abbassioun K. Radiation-induced tumors of the central nervous system occurring in childhood and adolescence. Four unusual lesions in three patients and a review of the literature. Childs Nerv Syst 2000; 16 (07) 390-397
45 Béhin A, Delattre JY. Complications of radiation therapy on the brain and spinal cord. Semin Neurol 2004; 24 (04) 405-417
46 Tsui K, Gajjar A, Li C. et al. Subsequent neoplasms in survivors of childhood central nervous system tumors: risk after modern multimodal therapy. Neuro-oncol 2015; 17 (03) 448-456
47 Albertsson-Wikland K, Lannering B, Márky I, Mellander L, Wannholt U. A longitudinal study on growth and spontaneous growth hormone (GH) secretion in children with irradiated brain tumors. Acta Paediatr Scand 1987; 76 (06) 966-973
48 Oberfield SE, Allen JC, Pollack J, New MI, Levine LS. Long-term endocrine sequelae after treatment of medulloblastoma: prospective study of growth and thyroid function. J Pediatr 1986; 108 (02) 219-223
49 Shalet SM, Beardwell CG, Morris-Jones PH, Pearson D. Pituitary function after treatment of intracranial tumours in children. Lancet 1975; 2 (7925): 104-107
50 Vassilopoulou-Sellin, Klein MJ, Moore III BD, Reid HL, Ater J, Zietz HA. Efficacy of growth hormone replacement therapy in children with organic growth hormone deficiency after cranial irradiation. Horm Res 1995; 43 (05) 188-193
51 Clarson CL, Del Maestro RF. Growth failure after treatment of pediatric brain tumors. Pediatrics 1999; 103 (03) E37
52 Ogilvy-Stuart AL, Shalet SM, Gattamaneni HR. Thyroid function after treatment of brain tumors in children. J Pediatr 1991; 119 (05) 733-737
53 Shore RE, Woodard E, Hildreth N, Dvoretsky P, Hempelmann L, Pasternack B. Thyroid tumors following thymus irradiation. J Natl Cancer Inst 1985; 74 (06) 1177-1184
54 Brinkman TM, Krasin MJ, Liu W. et al. Long-term neurocognitive functioning and social attainment in adult survivors of pediatric CNS tumors: results from the St Jude Lifetime Cohort Study. J Clin Oncol 2016; 34 (12) 1358-1367
55 Armstrong CL, Hunter JV, Ledakis GE. et al. Late cognitive and radiographic changes related to radiotherapy: initial prospective findings. Neurology 2002; 59 (01) 40-48
56 Imperato JP, Paleologos NA, Vick NA. Effects of treatment on long-term survivors with malignant astrocytomas. Ann Neurol 1990; 28 (06) 818-822
57 Wassenberg MW, Bromberg JE, Witkamp TD, Terhaard CH, Taphoorn MJ. White matter lesions and encephalopathy in patients treated for primary central nervous system lymphoma. J Neurooncol 2001; 52 (01) 73-80
58 Gutiérrez AN, Westerly DC, Tomé WA. et al. Whole brain radiotherapy with hippocampal avoidance and simultaneously integrated brain metastases boost: a planning study. Int J Radiat Oncol Biol Phys 2007; 69 (02) 589-597
59 Abayomi OK. Pathogenesis of cognitive decline following therapeutic irradiation for head and neck tumors. Acta Oncol 2002; 41 (04) 346-351
60 Armstrong CL, Corn BW, Ruffer JE, Pruitt AA, Mollman JE, Phillips PC. Radiotherapeutic effects on brain function: double dissociation of memory systems. Neuropsychiatry Neuropsychol Behav Neurol 2000; 13 (02) 101-111
61 Moretti R, Torre P, Antonello RM. et al. Neuropsychological evaluation of late-onset post-radiotherapy encephalopathy: a comparison with vascular dementia. J Neurol Sci 2005; 229-230: 195-200
62 Chapman CA, Waber DP, Bernstein JH. et al. Neurobehavioral and neurologic outcome in long-term survivors of posterior fossa brain tumors: role of age and perioperative factors. J Child Neurol 1995; 10 (03) 209-212
63 Copeland DR, deMoor C, Moore III BD, Ater JL. Neurocognitive development of children after a cerebellar tumor in infancy: a longitudinal study. J Clin Oncol 1999; 17 (11) 3476-3486
64 Kiltie AE, Lashford LS, Gattamaneni HR. Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old. Med Pediatr Oncol 1997; 28 (05) 348-354
65 Walter AW, Mulhern RK, Gajjar A. et al. Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital. J Clin Oncol 1999; 17 (12) 3720-3728
66 Spiegler BJ, Bouffet E, Greenberg ML, Rutka JT, Mabbott DJ. Change in neurocognitive functioning after treatment with cranial radiation in childhood. J Clin Oncol 2004; 22 (04) 706-713
67 Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 2004; 5 (07) 399-408
68 Mostow EN, Byrne J, Connelly RR, Mulvihill JJ. Quality of life in long-term survivors of CNS tumors of childhood and adolescence. J Clin Oncol 1991; 9 (04) 592-599
69 Compas BE. Neuroplasticity-based cognitive remediation for pediatric brain tumor survivors (CRPBT). Clinical Trials.gov Identifier: NCT02666066. Sponsor: Maastricht. Radiat Oncol 2014
70 Butler RW, Copeland DR. Attentional processes and their remediation in children treated for cancer: a literature review and the development of a therapeutic approach. J Int Neuropsychol Soc 2002; 8 (01) 115-124
71 Butler RW, Fairclough DL, Katz ER. et al. Intellectual functioning and multi-dimensional attentional processes in long-term survivors of a central nervous system related pediatric malignancy. Life Sci 2013; 93 (17) 611-616
72 Sohlberg MM, Ehlhardt L, Kennedy M. Instructional techniques in cognitive rehabilitation: a preliminary report. Semin Speech Lang 2005; 26 (04) 268-279
73 Thompson SJ, Leigh L, Christensen R. et al. Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer. J Clin Oncol 2001; 19 (06) 1802-1808
74 Louis DN, Perry A, Reifenberger G. et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 2016; 131 (06) 803-820
75 Lin CY, Erkek S, Tong Y. et al. Active medulloblastoma enhancers reveal subgroup-specific cellular origins. Nature 2016; 530 (7588): 57-62
76 Hovestadt V, Ayrault O, Swartling FJ, Robinson GW, Pfister SM, Northcott PA. Medulloblastomics revisited: biological and clinical insights from thousands of patients. Nat Rev Cancer 2020; 20 (01) 42-56
77 Northcott PA, Jones DT, Kool M. et al. Medulloblastomics: the end of the beginning. Nat Rev Cancer 2012; 12 (12) 818-834
78 International Cancer Genome Consortium PedBrain Tumor Project. Recurrent MET fusion genes represent a drug target in pediatric glioblastoma. Nat Med 2016; 22 (11) 1314-1320
79 Mazurowski MA, Clark K, Czarnek NM, Shamsesfandabadi P, Peters KB, Saha A. Radiogenomics of lower-grade glioma: algorithmically-assessed tumor shape is associated with tumor genomic subtypes and patient outcomes in a multi-institutional study with The Cancer Genome Atlas data. J Neurooncol 2017; 133 (01) 27-35
80 Mazurowski MA. Radiogenomics: what it is and why it is important. J Am Coll Radiol 2015; 12 (08) 862-866